Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- RNG +15.6%, RHI +8.8%, ENVA +3.5%, BAH +3.3%, MXL +3.0%, RCI +2.2%, KN +2.2%, COLB +2.1%, EAF +2.0%, OMC +1.8%, BCPC +1.6%, ITG +1.4%
Other news:
- ZLAB +12.2% (Reported an 81.8% response rate for zocilurtatug pelitecan plus atezolizumab in first-line extensive-stage small cell lung cancer.)
- AMTB +5.5% (Expanded its share repurchase authorization to $50 million and extended the program through December 2027.)
- SKHY +4.3% (Discontinued Solidigm’s potential IPO review amid semiconductor volatility while keeping its investment needs and growth plans unchanged.)
- GRC +3.9% (Raised its quarterly dividend 5.3% to $0.20 per share, payable December 10.)
- ADEA +3.4% (Renewed a multi-year media intellectual property licensing agreement with TCL for smart TV technologies.)
- IQMX +3.3% (Will install an IQM Spark quantum computer in Madrid with Telefónica by year-end, its third Spanish deployment.)
- BBD +3.0% (Authorized repurchases of up to 106.6 million shares over 18 months beginning November 8.)
- HURN +2.9% (Will join the S&P SmallCap 600 before trading opens November 2, replacing Supernus Pharmaceuticals.)
- ZYME +2.5% (Licenses ZW209 to Roche for up to $813 million in payments plus tiered royalties.)
- FCNCA +2.3% (Authorized a new 2027 share repurchase program of up to $1.2 billion.)
- GPRK +2.0% (Received tenders for $266.8 million of 8.75% senior notes due 2030 in its cash offer.)
- RAPP +1.7% (Director purchased 35,714 shares at $27.28 each, totaling approximately $974,280.)
- USO +1.7% (Iran threatened attacks on U.S. bases, warships and civilian targets in Gulf countries if U.S. strikes resume.)
- JKS +1.5% (Changed its name to Jinko Holdings after shareholder approval, reflecting its evolution into a diversified holding company.)
- RMBS +1.3% (Adopted ChipAgents’ AI platform companywide and made an undisclosed strategic investment in the chip-design startup.)